jamesmaggs12 Jan 2010 16:53
Oh well, hope it works out this time. A nurse is a better option anyway, they're used to clearing up after us men!
AKT and PYM are both in the buying window at the moment. I can't see either of them going lower, (unless they go bump), but they may not rise for a while either. If you don't mind tying funds up, they are a great buy (IMHO) and will reward you eventually. Sadly, I haven't got that much to tie up at the moment, so I need to keep an eye on them. PYM could take off at any time, AKT is a bit more predictable.
The situation is briefly,
AKT are awaiting an appeal against the decision by the EMA to refuse marketing authority for their lead brain tumour drug Cerepro. If this is successful, SP will increase to around 50p, if it fails, SP will stay where it is or drop further. I expect a decision by April / May.
PYM are still developing Cogane, the Alzheimer's / Parkinson's preventitive drug. The reason that the SP fell was purely due to the Placing and Open Offer of a further 252,000,000 shares @ 10p. I think they decided to increase the funding whilst the company was in favour. If and when Cogane is approved, again, IMHO, the SP will rocket. Imagine the effect of a drug that can CURE and PREVENT those two terrible diseases.